Taken together, these results suggested that anlotinib treatment inhibited tumor cell proliferation and invasion and promoted apoptosis via cell cycle arrestment by inactivating the VEGF/PI3K/AKT signaling pathway. This evidence concerns the gene VEGFA and neoplasm.